PE ratio relative to earnings growth — is the valuation justified?
| Symbol | Company | PEG | P/E | Growth | vs MDT |
|---|---|---|---|---|---|
| BSX | Boston Scientific Corporation | 0.30 | 19.1 | 63.3% | — |
| PODD | Insulet Corp. | 0.36 | 35.6 | 99.9% | — |
| ZBH | Zimmer Biomet Holdings, Inc. | 0.65 | 23.9 | 36.8% | — |
| SYK | Stryker Corporation | 2.64 | 39.0 | 14.8% | — |
| DXCM | DexCom, Inc. | 3.04 | 31.4 | 10.3% | — |